2010
ANNUAL REPORTUTMD was able to maintain its excellent profitability in 2010, with operating and net profit margins close to 36% and 24%, respectively. This profitability resulted in earnings per share (eps) of $1.65, which allowed UTMD to pay $1.665 in cash dividends to its shareholders in 2010 ...
2009
ANNUAL REPORTIn 2009, Utah Medical Products, Inc. (UTMD) shareholders were rewarded with a 34% increase in share price and about a 4% cash dividend based on average share price during the year.
2008
ANNUAL REPORTDespite the difficult current economic environment and challenging operational year in 2009, I am confident in UTMD’s ability to survive and continue its long term performance of providing excellent shareholder returns.
2007
ANNUAL REPORTFor more than a decade, UTMD's product/market strategy has been a
pursuit of the development, manufacture and marketing of medical devices
that improve the quality of cost-effective care, based on a value-added
rather than commodity-oriented approach.
2006
ANNUAL REPORT
In 2006, Utah Medical Products, Inc. (UTMD) accomplished its plan
as outlined in last year's Management's Discussion and Analysis (MD&A)
section of this annual report. As a result, the Company was able to
return capital to its shareholders in the form of cash dividends in
the amount of $.74 per share, representing a 21% increase over the
2005 dividend.
